What is the clinical management for a patient with intact villi on biopsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Patients with Intact Villi on Biopsy

In patients with intact villi on duodenal biopsy, the clinical management should focus on evaluating for seronegative enteropathies and other conditions that may present with increased intraepithelial lymphocytes (IELs) without villous atrophy. 1

Diagnostic Considerations

Initial Evaluation

  • Confirm proper orientation and quality of biopsy specimens with an experienced gastrointestinal pathologist to ensure accurate assessment of villous architecture 1
  • Quantify intraepithelial lymphocytes (IELs) - increased IELs (≥25/100 enterocytes) with normal villous architecture may represent early celiac disease or other conditions 2
  • Review all available serologic testing for celiac disease, including:
    • IgA tissue transglutaminase (tTG) antibodies
    • Total IgA levels (to rule out IgA deficiency)
    • IgA endomysial antibodies (EMA)
    • IgA/IgG deamidated gliadin peptide (DGP) antibodies 1

HLA Testing

  • Perform HLA-DQ2/DQ8 typing if not previously done - a negative result effectively rules out celiac disease (<1% of celiac patients are negative for both) 1
  • HLA typing is particularly useful in patients who are self-treated on a gluten-free diet without prior proper testing 1

Differential Diagnosis for Intact Villi with Increased IELs

Celiac Disease-Related

  • Early or developing celiac disease (may have positive serology but intact villi) 3
  • Seronegative celiac disease (negative serology but responds to gluten-free diet) 1

Non-Celiac Causes

  • Autoimmune disorders (Hashimoto's thyroiditis, Graves' disease, rheumatoid arthritis, etc.) 1, 4
  • Inflammatory bowel disease, particularly Crohn's disease 5
  • Medication-related (NSAIDs, olmesartan, mycophenolate mofetil) 1, 4
  • Infections (H. pylori gastritis, giardiasis, viral infections) 1, 2
  • Post-infectious diarrhea 1
  • Food protein intolerances (non-celiac gluten sensitivity, cow's milk, soy) 1, 2
  • Small intestinal bacterial overgrowth 1, 4

Management Algorithm

For Suspected Celiac Disease

  1. If celiac serology is positive with intact villi:

    • Consider early/developing celiac disease
    • Recommend gluten-free diet (GFD) trial for 6 months
    • Monitor clinical response and repeat serology 1, 3
  2. If celiac serology is negative with intact villi but increased IELs:

    • Check HLA-DQ2/DQ8 status
    • If HLA-positive: Consider trial of GFD for 6 months
    • If HLA-negative: Celiac disease is effectively ruled out 1
  3. For patients already on a self-imposed GFD:

    • Perform HLA typing
    • If HLA-positive: Consider gluten challenge followed by repeat biopsy
    • If HLA-negative: Discontinue GFD and investigate other causes 1

For Non-Celiac Etiologies

  • Screen for autoimmune disorders (thyroid function tests, autoantibodies) 4
  • Review medication history, particularly NSAIDs and olmesartan 1
  • Test for H. pylori infection 1, 2
  • Consider stool studies for parasites and bacterial overgrowth 1
  • Evaluate for inflammatory bowel disease, especially if focal gastritis is present on gastric biopsies 5

Follow-up Recommendations

  • For patients with suspected early celiac disease or seronegative celiac disease on GFD:

    • Repeat duodenal biopsy in 12-24 months to assess for histological changes 1
    • Follow standard biopsy protocol: 4 biopsies from second part of duodenum plus 2 from duodenal bulb 1
  • For patients with persistent symptoms despite negative workup:

    • Consider repeat biopsy with samples from the jejunum 1
    • Video capsule endoscopy may provide additional diagnostic information 1

Important Caveats

  • Intact villi with increased IELs is a nonspecific finding but should not be ignored, as it may represent early celiac disease in approximately 10% of cases 4
  • The absence of villous atrophy does not exclude celiac disease, especially in early stages 1, 2
  • Patchy distribution of intestinal lesions may lead to sampling errors; multiple biopsies are essential 1
  • Histological features alone cannot reliably distinguish between celiac and non-celiac causes of increased IELs 4
  • Patients with normal villi but increased IELs may still benefit from a gluten-free diet if they have positive celiac serology 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2005

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.